1. Home
  2. ABCL vs NVTS Comparison

ABCL vs NVTS Comparison

Compare ABCL & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • NVTS
  • Stock Information
  • Founded
  • ABCL 2012
  • NVTS 2014
  • Country
  • ABCL Canada
  • NVTS United States
  • Employees
  • ABCL N/A
  • NVTS N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • NVTS Semiconductors
  • Sector
  • ABCL Health Care
  • NVTS Technology
  • Exchange
  • ABCL Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • ABCL 818.2M
  • NVTS 762.1M
  • IPO Year
  • ABCL 2020
  • NVTS N/A
  • Fundamental
  • Price
  • ABCL $2.97
  • NVTS $3.26
  • Analyst Decision
  • ABCL Buy
  • NVTS Buy
  • Analyst Count
  • ABCL 3
  • NVTS 8
  • Target Price
  • ABCL $8.00
  • NVTS $4.75
  • AVG Volume (30 Days)
  • ABCL 3.2M
  • NVTS 6.5M
  • Earning Date
  • ABCL 02-18-2025
  • NVTS 02-27-2025
  • Dividend Yield
  • ABCL N/A
  • NVTS N/A
  • EPS Growth
  • ABCL N/A
  • NVTS N/A
  • EPS
  • ABCL N/A
  • NVTS N/A
  • Revenue
  • ABCL $32,962,000.00
  • NVTS $91,381,000.00
  • Revenue This Year
  • ABCL N/A
  • NVTS $8.34
  • Revenue Next Year
  • ABCL $36.56
  • NVTS $5.50
  • P/E Ratio
  • ABCL N/A
  • NVTS N/A
  • Revenue Growth
  • ABCL N/A
  • NVTS 38.99
  • 52 Week Low
  • ABCL $2.34
  • NVTS $1.75
  • 52 Week High
  • ABCL $5.62
  • NVTS $7.40
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 50.75
  • NVTS 47.58
  • Support Level
  • ABCL $2.81
  • NVTS $2.92
  • Resistance Level
  • ABCL $3.09
  • NVTS $3.68
  • Average True Range (ATR)
  • ABCL 0.20
  • NVTS 0.38
  • MACD
  • ABCL -0.02
  • NVTS -0.09
  • Stochastic Oscillator
  • ABCL 30.28
  • NVTS 20.86

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: